Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.
Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study. Cancer. 2003 Jan 01; 97(1):105-13.
-
Adolescent
-
Antineoplastic Agents
-
Child
-
Child, Preschool
-
Chromosomes, Human, Pair 12
-
Chromosomes, Human, Pair 21
-
Core Binding Factor Alpha 2 Subunit
-
Disease-Free Survival
-
DNA Primers
-
Female
-
Follow-Up Studies
-
Humans
-
Infant
-
Infant, Newborn
-
Male
-
Neoplasm, Residual
-
Oncogene Proteins, Fusion
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma
-
Prospective Studies
-
Reverse Transcriptase Polymerase Chain Reaction
-
RNA, Messenger
-
RNA, Neoplasm
-
Translocation, Genetic
-
Treatment Outcome